<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000979.v1.p1" parentStudy="phs000979.v1.p1" createDate="2015-08-24" modDate="2015-12-15">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Barbara K. Lipska, PhD</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>IRP</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Gene Expression in Postmortem DLPFC and Hippocampus from Schizophrenia and Mood Disorders</StudyNameEntrez>
	<StudyNameReportPage>Gene Expression in Postmortem DLPFC and Hippocampus from Schizophrenia and Mood Disorders</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Whole-genome expression analysis across nine major mental disorders with emphasis on schizophrenia (SZ), bipolar disorder (BP) and major depression (MDD) as compared to controls (C), allows examining disease-specific changes and potential common molecular pathogenic mechanisms. Three relevant regions were assessed: hippocampus (mRNA) and dorsolateral prefrontal cortex (mRNA), and in control tissue, dura (mRNA) as well as genotypes, for a large cohort of individuals. We found a pattern of downregulation of gene expression in SZ, differences in expression between SZ and BP, and between the regions. 37 genes were differentially expressed in SZ vs C in both DLPFC and Hippocampus.</p> <p><b>Table 1</b>: The number of subjects in each array and mental disorder.</p> <p> <table border="1"> <tr> <th></th> <th>Anxiety</th> <th>Williams</th> <th>Tics</th> <th>Neuro</th> <th>Control</th> <th>Bipolar</th> <th>PTSD</th> <th>Autism</th> <th>MDD</th> <th>OCD</th> <th>ED</th> <th>Substance</th> <th>Schizo</th> </tr> <tr> <td>Genotyping (SNP Array)</td> <td></td> <td>2</td> <td>3</td> <td></td> <td>345</td> <td>76</td> <td></td> <td>14</td> <td>148</td> <td>7</td> <td>7</td> <td>7</td> <td>190</td> </tr> <tr> <td>Hippocampus (mRNA)</td> <td></td> <td>1</td> <td>3</td> <td></td> <td>281</td> <td>51</td> <td></td> <td>7</td> <td>88</td> <td>5</td> <td>1</td> <td>6</td> <td>134</td> </tr> <tr> <td>Dura Mater (mRNA)</td> <td></td> <td></td> <td></td> <td></td> <td>79</td> <td></td> <td></td> <td></td> <td></td> <td></td> <td></td> <td></td> <td>75</td> </tr> <tr> <td>DLPFC (mRNA)</td> <td>1</td> <td>2</td> <td>3</td> <td>2</td> <td>347</td> <td>97</td> <td>12</td> <td>15</td> <td>150</td> <td>9</td> <td>2</td> <td>5</td> <td>202</td> </tr> </table> </p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Postmortem brains were collected at the Human Brain Collection Core, NIMH with informed consent from the legal next of kin (NIMH protocol 90-M-0142), and at the Brain and Tissue Bank for Developmental Disorders of the NICHD (contracts NO1-HD-4-3368 and NO1-HD-4-3383) and through the Stanley Medical Research Institute. Clinical characterization, neuropathological screening, toxicological analyses, and dissection of the dorsolateral prefrontal cortex were performed as previously described (<a href="http://www.ncbi.nlm.nih.gov/pubmed/16997002">Lipska et al. 2006</a>). All patients met DSM-IV criteria for a lifetime Axis I diagnosis of schizophrenia or schizoaffective disorder, bipolar disorder or major depression, and controls had no history of psychological or psychiatric problems and negative toxicology results.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Schizophrenia"/>
		<Disease vocab_source="MESH" vocab_term="Bipolar Disorder"/>
		<Disease vocab_source="MESH" vocab_term="Major Depressive Disorder"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Barbara K. Lipska, PhD</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>IRP</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIMH</DacName>
      <DacFullName>NIMH</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000979.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000979.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000979.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
